DataMeds AI, Inc.
Nasdaq · Services · Wholesale-Drugs, Proprietaries & Druggists' Sundries · Tampa, FL
MEDS chart
What traders are saying about $MEDS
Latest postsDataMeds AI, Inc. news
- Form SCHEDULE 13G DataMeds AI, Inc. Filed by: Hyperscale Data, Inc.
StreetInsider ·
- A $1 conversion assumption underlies a reported stake in DataMeds AI (MEDS).
Stock Titan ·
- An amended resale plan would send no selling-holder proceeds to DataMeds AI (MEDS).
Stock Titan ·
- An illustrative $0.50 conversion case shows potential dilution for DataMeds AI (MEDS) holders.
Stock Titan ·
- DataMEDS Completes First Compounded Peptide Sale
grafa.com ·
- DataMEDS AI Announces Corexa Pharmacy's First Commercial Sale of Compounded Peptides Under FDA Enforcement Discretion Policy
The Asheville Citizen Times ·
- A pharmacy made its first sale of a compounded peptide. The FDA has not approved these drugs.
Stock Titan ·
- DataMEDS AI to launch GLP-1 patient management program
Chain Drug Review ·
- DataMeds AI Signs Preliminary Agreement With Florida Health Insurer for GLP-1 Patient Management App
investorshub.advfn.com ·
- DataMEDS AI Signs MOU to Deploy Health Lives Here GLP-1 Patient Management Program with Florida-Based HMO
Akron Beacon Journal ·
- Two agreements remain in force as DataMeds AI (MEDS) cancels its stock-based deal proposal.
Stock Titan ·
- DataMEDS AI, Inc. (MEDS) Signs Non-Binding HMO MOU for 2027 Rollout
TradingView ·
DataMeds AI, Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $23.3M | $18.1M | – |
| Net income | -$101.3M | -$6.9M | -$2.9M |
| Diluted EPS | $-1.43 | $-0.15 | $-0.06 |
| Total assets (year end) | $30.5M | $57.3M | $338,364 |
| Cash and equivalents (year end) | $42,571 | $1.0M | $1,364 |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About DataMeds AI, Inc.
- Ticker
- MEDS (Nasdaq)
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- Headquarters
- Tampa, FL
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 2030763
- Former names
- Wellgistics Health, Inc., Danam Health, Inc
Frequently asked questions
What exchange is DataMeds AI, Inc. listed on?
DataMeds AI, Inc. trades on the Nasdaq under the ticker symbol MEDS.
What industry is DataMeds AI, Inc. in?
DataMeds AI, Inc. is classified by the SEC under "Wholesale-Drugs, Proprietaries & Druggists' Sundries", part of the Services sector on StockTweeting.
Where is DataMeds AI, Inc. headquartered?
DataMeds AI, Inc.'s business address on file with the SEC is in Tampa, FL.
When does DataMeds AI, Inc.'s fiscal year end?
DataMeds AI, Inc.'s fiscal year ends on December 31.
How much revenue did DataMeds AI, Inc. report?
DataMeds AI, Inc. reported $23.3M in revenue for calendar year 2025, according to its SEC filings.